Cargando…
Which Stent for Diabetic Patient With Coronary Artery Disease?
[Figure: see text]
Autores principales: | Hong, Myeong-Ki, Hong, Sung-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627909/ https://www.ncbi.nlm.nih.gov/pubmed/36338171 http://dx.doi.org/10.1016/j.jacasi.2021.07.010 |
Ejemplares similares
-
Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2019) -
Association between in-stent neointimal characteristics and native coronary artery disease progression
por: Jung, Hae Won, et al.
Publicado: (2021) -
Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015) -
Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011) -
Effects of Combination Therapy with Celecoxib and Doxycycline on Neointimal Hyperplasia and Inflammatory Biomarkers in Coronary Artery Disease Patients Treated with Bare Metal Stents
por: Kim, Won Ho, et al.
Publicado: (2012)